Expert Opinion on Therapeutic Targets logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 13, Number 7, July 2009

< previous issue | all issues | next issue >

Original Research

A20 is overexpressed in glioma cells and may serve as a potential therapeutic target
pp. 733-741(9)
Authors: Guo, Qingdong; Dong, Hui; Liu, Xiaonan; Wang, Chunmei; Liu, Nannan; Zhang, Jianning; Li, Bing; Cao, Weidong; Ding, Tianbing; Yang, Zengyue; Zhang, Xiang

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein
pp. 743-751(9)
Authors: Kappelle, Paul JWH; Zwang, Louwerens; Huisman, Menno V; Banga, Jan Dirk; Sluiter, Wim J; Dallinga-Thie, Geesje M; Dullaart, Robin PF

Reviews

Peptide deformylase - a promising therapeutic target for tuberculosis and antibacterial drug discovery
pp. 753-765(13)
Authors: Sharma, Anshika; Khuller, Gopal K; Sharma, Sadhna

Targeting histone deacetylases for heart failure
pp. 767-784(18)
Authors: Bush, Erik W; McKinsey, Timothy A

Targeting the Nrf2 pathway against cardiovascular disease
pp. 785-794(10)
Authors: Li, Jinqing; Ichikawa, Tomonaga; Janicki, Joseph S; Cui, Taixing

Potential therapeutic targets in obstructive sleep apnoea
pp. 795-809(15)
Authors: Saboisky, Julian P; Chamberlin, Nancy L; Malhotra, Atul

EMP3 as a candidate tumor suppressor gene for solid tumors
pp. 811-822(12)
Authors: Fumoto, Shoichi; Tanimoto, Keiji; Hiyama, Eiso; Noguchi, Tsuyoshi; Nishiyama, Masahiko; Hiyama, Keiko

Targeting CD133 antigen in cancer
pp. 823-837(15)
Authors: Ferrandina, Gabriella; Petrillo, Marco; Bonanno, Giuseppina; Scambia, Giovanni

Dickkopf-1: a suitable target for the management of myeloma bone disease
pp. 839-848(10)
Authors: Gavriatopoulou, Maria; Dimopoulos, Meletios-Athanasios; Christoulas, Dimitrios; Migkou, Magdalini; Iakovaki, Marina; Gkotzamanidou, Maria; Terpos, Evangelos

Prostaglandin E2 synthase inhibition as a therapeutic target
pp. 849-865(17)
Authors: Iyer, Jitesh P; Srivastava, Punit K; Dev, Rishabh; Dastidar, Sunanda G; Ray, Abhijit

Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models
pp. 867-887(21)
Authors: Kapitulnik, Jaime; Pelkonen, Olavi; Gundert-Remy, Ursula; Dahl, Svein G; Boobis, Alan R

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page